Glutamate is a highly active metabolite in the cerebral cortex. It can be converted into a-oxoglutarate by transamination or dehydrogenation; it can be decarboxylated to y-aminobutyrate, and its carbon skeleton can be synthesized from glucose and intermediates of glucose metabolism (see Waelsch
1960). The extent to which the various reactions occur depends partly on environmental circumstances; for example, low concentrations of glucose favour the removal of glutamate and high concentrations prevent it (Waelsch, 1949; Cravioto, Massieu & Izquierdo, 1951; Takagaki, Hirano & Tsukada, 1957 (Nisonoff, Barnes, Enns & Schuching, 1954; Jenkins & Sizer, 1959) . A mixture of 15,umoles of a-oxo [5-14C] glutarate (60 pc) and 75,moles of L-glutamate, dissolved in 2-5 ml. of water, plus 0 5 ml. of 0-1 M-phosphate-buffer, pH 8-0, was incubated for 3 hr. at room temperature with 0-1 ml. of aspartate aminotransferase (2 mg./ml.; C. F. Boehringer und Soehne, Mannheim, Germany). L-[5-14C]Glutamate was separated from the reaction mixture by the method of Haslam & Krebs (1963) and the material obtained was neutralized and dissolved in 0 375 ml. of water plus 4-625 ml. of 0 2M-sodium glutamate to give a 0-2M solution with a specific activity of approx. 50 pc/m-mole. This solution was stored at -18°. D-[1-14C]Glutamate was prepared from DL-[1-14C]-glutamate by incubation of the latter with a suspension of Clostridium welchii as in the manometric estimation of glutamate (Krebs, 1948) . When no further CO2 was evolved the vessel contents were deproteinized with perchloric acid and, after precipitation of potassium perchlorate with 5N-KOH, D-[l-14C]glutamic acid was isolated by paper chromatography with the butan-l-ol-propionic acid-water solvent of Benson et al. (1950) . After elution from the paper with waterandfreeze-drying, the D-[1-14C]glutamic acid obtained was dissolved in 0-2M-sodium D-glutamate to give a final specific activity of about 20,uc/m-mole. The final product yielded no 14CO2 on addition to a suspension of Clostridium welchii.
Sodium pyruvate was prepared from technical pyruvic acid as described by Bartley & Davies (1954) . Sodium parapyruvate was obtained by hydrolysis with 0 5M-Na2CO3 solution of the my-lactone of parapyruvic acid (y-hydroxy-ymethyl-a-oxoglutaric acid) prepared as described by de Jong (1901) . All other materials were analytical reagent grade (British Drug Houses Ltd.).
Tis8ue preparations. Homogenates of rat-brain cerebral cortex and slices of adult guinea-pig cerebral cortex were used. The animals were killed by a sharp blow to the neck followed by decapitation.
For the preparation of homogenates the brains were removed and immersed in ice-cooled 0154M-KCI for 2 min. The weighed grey matter was homogenized in a stainlesssteel Potter-Elvehjem homogenizer with 2-3 vol. of cold (00) incubation medium containing (per 100 ml.) 52 ml. of 0 154M-KCI, 10 ml. of 0 lM-potassium phosphate buffer, pH 7.4, 8-3 ml. of 02 m-MgCl2, 8-0 ml. of m-glycylglycine buffer (pH adjusted to 7-4 with NaOH) and water to 100 ml. This is a modification of the medium of Case & McIlwain (1951) , incorporating a higher concentration of phosphate. After homogenization further medium was added to the homogenate to give a final volume of 7-5 ml./ g. of brain tissue. The homogenates were incubated at 300 in conical Warburg vessels with 02 in the gas phase. Each vessel contained 3 0 ml. of homogenate. This was added to 1-0 ml. of an ice-cooled solution comprising 0-2 ml. of 0-02M-AMP and 0-02M-ATP (both as sodium salts), 0-2 ml.
of 0 154M-KHCOs, substrates (usually as 0-2M solutions of the sodium salts) and 0-154m-KCI to volume, prepared before the killing of the animal. The final tissue concentration was 10 % (w/v). The side arm contained 0 5 ml. of 2N-HCI and the centre well 0-2 ml. of C02-free 2i-NaOH. The vessel contents were kept at 00 until the zero time of the incubation, which was continued for 20-40 min. and was terminated by tipping the 2N-HCI from the side arms. When the respiratory 14CO2 was to be collected, shaking was continued after addition of acid to the main compartments until no further change in gas pressure occurred (approx. 1 hr.). The acidified tissue suspensions were stored at -180 until analysed. Rat-liver homogenates used for comparison with brain homogenate were prepared and incubated as described by Haslam & Krebs (1963) .
Slices of guinea-pig cerebral cortex were incubated aerobically in Warburg vessels at 370, the suspending medium being a phosphate saline (Krebs, 1933) from which calcium was omitted. Slices (about 200 mg. fresh wt.) were blotted with filter paper, weighed on a torsion balance and placed in the incubation medium in Warburg vessels with two side arms. One side arm contained substrates (usually as 0-2 M-solutions of the sodium salts) and the other 0 5 ml. of 2N-HCl. Carbon dioxide-free 2N-NaOH was placed in the centre wells. The gas spaces of the vessels were filled with 02 and the vessels were shaken at 370 for 5 min., before the substrates (if any) were added from a side arm to give a final volume of 4 0 ml. (including the slices). The initial concentration of added substrates was 2-5 mM. Incubation was then continued for 90-120 min. and was terminated by tipping 2-N-HCI from the second side arm. Further details were as described for brain homogenates, except that before storage the slices plus acidified incubation medium were homogenized in a glass Potter-Elvehjem homogenizer. The slices and incubation medium were not analysed separately.
Chemical analy8e8. Glutamate plus glutamine and aspartate were estimated manometrically by the method of Krebs & Bellamy (1960) . No attempt was made to differentiate in the analyses between glutamate and glutamine, so that measurements of glutamate removal may include endogenous glutamine and refer to glutamate metabolized by reactions other than glutamine synthesis. Alanine was estimated by the ninhydrin reaction as described by Krebs & Bellamy (1960) , after chromatographic separation by the two-dimensional solvent system described below. Pyruvate Vol. 88 567
and oc-oxoglutarate were estimated by the method of Holzer & Holldorf (1957) . Citrate was determined as de. scribed by Taylor (1953 Kornberg (1958) and with butan-l-olpropionic acid-water (47:22:31, by vol.; Benson et al. 1950) . The details of the methods used were as described by Large, Peel & Quayle (1961) .
Radioactive tracer techniquev. The general techniques used and the corrections applied have been described by Sakami (1955) and Haslam & Krebs (1963) . formation (Table 3 ). The small increase in the glutamate content of the homogenate during the incubation was probably a result of proteolysis (Bellamy, 1962 (Table 5) . These results and the absence of any appreciable oc-oxoglutarate accumulation are in contrast with the effects of addition of pyruvate and suggest that in the homogenates fewer glucose carbon atoms than pyruvate carbon atoms entered the tricarboxylic acid cycle, probably because of the low rate of glycolysis in homogenates.
As shown in Table 5 , the whole of the [1-14C]-glutamate added to vessels 1, 2 and 3 of The aspartate formed was radioactive and the specific activity of C-4 of aspartate relative to C-5 of [5-14C]glutamate was 0-46. This is consistent with the oxidation of glutamate through the tricarboxylic acid cycle, which would lead to an equal distribution of the 14C between the two carboxyl groups of aspartate, so giving a theoretical relative specific activity of 0-5 for C-1 and C-4.
When shows that pyruvate had largely replaced oxaloacetate as the a-oxo acid initiating glutamate oxidation by transamination, and that transamination rather than dehydrogenation was the main primary reaction of glutamate under the test conditions. The differences in the effects of pyruvate in liver and brain, including the stimulation of glutamate removal by pyruvate in liver and inhibition in brain, can be attributed to the much higher alanineaminotransferase activity in lver. Data on the aminotransferases of liver and cerebral cortex are given in Table 9 . The activity of the alanine aminotransferase of liver was about 12 % of that of the aspartate aminotransferase in liver and about 2 % in cerebral cortex (see also Cohen & Hekhuis, 1941; Matzelt, Oriol-Bosch & Voigt, 1962; Fellenberg, Eppenberger, Richterich & Aebi, 1962 (11) citrate -a oc-oxoglutarate.
This list is not a comprehensive survey of the reactions involving glutamate in cerebral cortex, but is limited to those which are relevant to the subsequent discussion. The experimental findings do not support the occurrence of reactions resulting in the conversion of glutamate into aspartate via y-decarboxylation as proposed by Cohen et al. (1962) .
Homogenates of cerebral cortex. Since aspartate and alanine do not take part in any reactions other than (1) and (2) their yields are a measure of these reactions. The yield of y-aminobutyrate, on the other hand, represents only the minimum extent of (3) since some y-aminobutyrate can be removed by (6). Aspartate was formed in quantities equivalent to 80-90% of the glutamate removed when the latter was the sole substrate. Under these conditions no alanine was detectable and the amount of y-aminobutyrate found was less than 8 % of the glutamate removed. This leaves some 10 % of the glutamate unaccounted for, which has probably been removed by the glutamate-dehydrogenase reaction (4). These results, in combination with the effects of malonate, show that glutamate was mainly oxidized through transamination with oxaloacetate, followed by the conversion of the oc-oxoglutarate formed into oxaloacetate (reaction 5), as previously shown for brain mitochondria (Krebs & Bellamy, 1960) and for many other tissues (Krebs, 1950; M{iller & Leuthardt, 1950; Krebs & Bellamy, 1960; Borst & Slater, 1960; Jones & Gutfreund, 1961; Borst, 1962) .
Vol. 88 573 The fact that 14CO2 was formed from [5_14C]_ glutamate shows that some glutamate was metabolized beyond the stage of oxaloacetate, probably because the latter condensed with acetyl-CoA according to (10) . One turn of the tricarboxylic acid cycle (reactions 11 and 5) would then cause the complete release of 14C as 14CO2. Alternatively C-5 of glutamate could be set free as 14CO2 by reactions (8) and (9). The formation of 14CO2 from [5-14C]-glutamate accounted for about 10 % of the glutamate removed (the same value as the amount not accounted for by the recovery of the amino acids).
This confirms the earlier conclusion that about 10 % of the glutamate removed was metabolized by reaction (4). The data on the formation of 14CO2 from [1-14C]glutamate in the presence of malonate or parapyruvate, or under anaerobic conditions, show that reaction (3) accounted for not more than 10 % of the glutamate removed, a figure which corresponds to the contribution of the y-aminobutyrate pathway (see Roberts, 1956) (3), (6), (7) and (1). The latter sequence converts glutamate into aspartate via y-aminobutyrate. That aspartate may be a product of the oxidation of y-aminobutyrate has been shown by Tsukada, Hirano, Nagata & Matsutani (1960) .
Effects of glucose and pyruvate on the metabolisln of glutamate. Although added and endogenous glutamate are under some conditions readily oxidized by brain preparations in vitro, the concentration of glutamate in vivo is normally maintained at about 10 mM (Krebs, Eggleston & Hems, 1949; Schwerin et al. 1950) . Thus in vivo the oxidation of glucose either prevents the oxidation of glutamate or causes glutamate to be resynthesized as rapidly as it is utilized. The present experiments confirm the previous observations (Stern, Eggleston, Hems & Krebs, 1949; Waelsch, 1949; Takagaki et al. 1957) that glucose inhibits the removal of glutamate from brain slices and they also show that pyruvate has the same effect in brain homogenate. The almost complete suppression of aspartate formation by these substrates indicates that the reaction of glutamate which is inhibited is its transamination with oxaloacetate. The reason for the inhibition requires further investigation. The occurrence of a net transamination depends in the first instance upon the concentration of the reactants in relation to the equilibrium position. It is possible that the addition of glucose or pyruvate so affects the concentrations of oc-oxoglutarate and oxaloacetate as to make them unfavourable for a net transamination between glutamate and oxaloacetate. In fact the addition of pyruvate increased the concentration of oc-oxoglutarate in brain homogenate more than tenfold (Table 4 ). This concept is also supported by the observations made on liver homogenates, where on addition of pyruvate the transamination between glutamate and pyruvate supplanted that between glutamate and oxaloacetate, although the activity of the aspartate aminotransferase is very high (see also Ratner & Pappas, 1949) . As shown in (Tables 4 and 7 ). These observations have presumably the same basis as the incorporation of radioactivity from 14C-labelled pyruvate or glucose into the amino acids of brain (described by Winzler, Moldave, Rafelson & Pearson, 1952; Beloff-Chain, Catanzaro, Chain, Masi & Pocchiari, 1955 Busch, 1955; Kini & Quastel, 1959; Shrivastava & Quastel, 1962; Vrba, Gaitonde & Richter, 1962) . The dilution of labelled glutamate by glucose or pyruvate or the appearance of carbon atoms of glucose or pyruvate in unlabelled glutamate can be fully explained by the participation of glutamate in the following half-reaction of transamination (Nisonoff et al. 1954; Jenkins & Sizer, 1959; Velick & Vavra, 1962) Factor8 affecting the rate of appearance and disappearance of 14C in the free amino acid8 of tissues. The aminotransferase activities, and hence the rates of the exchange reactions, are of the same order in the major tissues such as liver, muscle, brain or kidney. If glucose carbon atoms are nevertheless incorporated more rapidly into the amino acid pool of brain, this must be due to factors other than aminotransferase activity. Most important of all is the rate at which glucose is converted into acetyl-CoA-a prerequisite for the formation of the oc-oxo acids. This is far more rapid in brain than in liver, kidney or resting muscle owing to the rather low rate of glycolysis of these tissues. Another factor is the pool size of glutamate, which is substantially greater in brain than in most other tissues of the rat (Schwerin et al. 1950) . A third factor operating when glucose is injected into the whole animal (Busch, Fujiwara & Keer, 1960; Vrba et al. 1962 ) is the fact that the blood supply of brain is relatively larger per unit of weight than that of muscle or liver. Thus more isotope reaches the brain. Finally added glucose may enter metabolic processes more rapidly in brain than in other tissues because of its low glucose content (Gey, 1956) , the average glucose concentration of brain being 8 mg./100 g. compared with 82 mg. in liver, 51 mg. in kidney and 22 mg. in muscle, and because of the inability of brain, in contrast with most other tissues, to rely on substrates other than glucose as a source of energy.
The conversion of a substrate into the intermediates of the tricarboxylic acid cycle is liable to depend on experimental conditions and these must therefore affect the appearance of substrate carbon atoms in glutamate. As the rate of glycolysis is greatly reduced by converting a tissue into an homogenate, it is not surprising that the glucose carbon atoms appear in glutamate in slices but not in homogenates.
These considerations are equally relevant to the interpretation of experiments in which the labelling of 14C02 is measured after the addition of 14C. labelled substrates (see Sacks, 1957 Sacks, , 1961 Allweis & Magnes, 1958; Sellinger et al. 1962) . Though the main principles discussed, especially the distinction between isotope exchange and metabolic incorporation, have already been clearly expressed by Albers & Jakoby (1960) Sellinger et al. 1962; Vrba et al. 1962 ). Thus Chain et al. (1962) report that addition of unlabelled glutamate or aspartate reduces the specific activity of the 14CO2 produced by slices of cerebral cortex respiring in the presence of uniformly labelled [14C] glucose and infer that the amino acids inhibit the oxidation of glucose and are therefore preferentially oxidized. However, this observation can also be explained by the retention of radioactivity in the amino acid Vol. 88 575 L-Aspartate 4-carboxy-lyase (EC 4.1.1.12) has been shown to be present in a number of microorganisms (for review, see Braunstein, 1960) . The enzyme, which is unusual in its strong stimulation by a-oxo acids, was partially purified by Nishimura, Manning & Meister (1962) and was shown to contain firmly bound pyridoxal 5'-phosphate; it has subsequently been crystallized from Achromobacter sp. (Wilson, 1963) and has been extensively purified from Alcaligenes faecali (Meister, Nishimura & Novogradsky, 1962) .
It is the main purpose of the present paper to describe some of the properties of the L-aspartate 4-carboxy-lyase of Achromobacter sp. and, in particular, to discuss the mode of binding of pyridoxal 5'-phosphate to the protein and to L-aspartate. A preliminary report of part of this work has been presented to The Biochemical Society (Wilson & Kornberg, 1963) .
METHODS AND MATERIALS
Preparation of L-aspartate 4-carboxy-lyase. The enzyme was purified by the procedure of Wilson (1963) except that the conditions of crystallization were modified to obtain more uniform crystals. The first crop of crystals was obtained by dialysis of the carboxymethylcellulose-treated extract ('Step V') against 02M-sodium acetate, pH 7-0, instead of against 0-1 M-buffer as previously described. It is important that the dialysis be performed without stirring of the buffer. The enzyme was recrystallized by the same procedure. The resulting crystals (Fig. 1) were regular hexagonal plates that became broken and less regular with time (the photographs shown in Fig. 1 were taken after the crystals had been stored for 3 days).
Two preparations of enzyme were used in most of the experiments described below. One had an initial specific activity of 107 units/mg. of protein and contained 1 mole of pyridoxal 5'-phosphate/120 000 g. of protein, and was used in the spectrophotometric experiments; the other had an initial specific activity of 90 units/mg. of protein and contained 1 mole of pyridoxal 5'-phosphate/60 000 g. of protein; this preparation was used in the ultracentrifugal studies (see Appendix and Fig. 2 ) and in the remaining experiments.
The enzyme was stable when stored in concentrated solution at pH 7 and 4°. Activity was lost very rapidly in dilute solution or at pH 5 0; it is recommended that dilution before assay be made in 0 5 % bovine serum albumin.
A solution of the second preparation of enzyme in 0-5M-sodium acetate, pH 7 0, containing 8-8 mg. of protein/ml., lost less than 15% of its activity, when assayed in the presence of pyruvate, after storage for 21 months. However, its activity assayed in the absence of pyruvate doubled after this storage. This stored enzyme, which was therefore stimulated less by pyruvate than was freshly prepared enzyme, is referred to below as 'aged' enzyme. A88ay method8. Method A. L-Aspartate 4-carboxy-lyase was assayed manometrically at 300. Evolution of C02 was measured for 30 min. after the addition of L-aspartate, and was linear with time and with enzyme concentration. The main compartments of Warburg flasks contained, in a final volume of 1-8 ml., 200 /moles of sodium acetate (pH 5 0), 0 5,mole of sodium pyruvate, and enzyme (2-2000 ug. of protein). L-Aspartate (20 ,umoles) was added from the side arm after equilibration for 15 min. One unit of enzyme is defined as that quantity which catalyses the evolution of 1 ,mole of C02/min. under these conditions. Method B. When lower substrate concentrations were required, the activity of the enzyme was measured by assay of the radioactivity of 14CO2 from the decarboxylation of L-[U-14C]aspartate. The complete system contained, in the main compartments of double-armed Warburg manometer cups, 200,umoles of sodium acetate (pH 5-0), 0-5p-mole of sodium pyruvate, 0-176Zg. of purified L-aspartate 4-carboxy-lyase, and water to bring the reaction volume to 2-0 ml. after the addition of the contents of the first side arm. The centre wells contained 0-2 ml. of 2N-KOH.
L-[U-14C]Aspartate (0.05-0.20,umole) was added from the
